Read the Documents (Part 2 of 2)

for Drs. Fauci and Rosenberg.  https://www.dandavidprize.org/prize/prize-nominations
Linda D. Simmons

NIH Ethics Office (NEO)
National Institutes of Health
Bethesda, MD
@nih.gov
 (NEO)
 (direct)
https://ethics.od.nih.gov

 Released by Chairman Rand Paul
From:  Weaver, Gretchen (NIH/OD) [E] < @od.nih.gov >
Sent:  Friday, January 29, 2021 3:18 PM
To: Jaffe, Holli Beckerman (NIH/OD) [E] < @od.nih.gov >
Subject:  RE: Dan David Prize

Holli:  Here is discussion from 2011.  If you can confirm that nothing has changed, including the
“attendant events” that are now mentioned on the web site, this should be helpful.  I did all of the
leg work.  Ed took this information to OGE and OGE accepted the award as bona fide even though
the subject area to be recognized changes, etc.:

The Dan David Foundation awards three $1 million Dan David Prizes each year (since 2002),
recognizing past, present, and future achievements.  For each time dimension, a field is chosen, and
one or more recipients are selected.  If more than one recipient is selected in a field, the cash prize is
shared.  The categories for 2012 are:  Past – History/Biography; Present – Plastic Arts; and Future –
Genome Research.  Notably, laureates donate 10% of their prize money to graduate students of
their choice.   NASA and DOE employees are among the prior recipients (they received the award in
2007).  International panels of experts in each of the fields to be recognized evaluate the nominees
based upon the description of each field of recognition posted on the web site and submit reports to
the Dan David Prize Board (an international panel selected by the Dan David Foundation Board).  The
DDP Board makes the final determination as to which nominee(s) in each category have achieved
that which the prize is intended to recognize (as described in the category descriptions).  More
information is available at: http://www.dandavidprize.org/ , including the composition of the DDP
Board.
After reviewing the web site, other publicly available information, and the materials our NASA
colleagues were able to provide, I made contact with the Chair of the Dan David Foundation Board,
Professor Itamar Rabinovich, and the administrative Director of the Prize, Ms. Smadar Fisher.  Based
on all of the information I have been able to obtain , it appears that the Prize program is “owned” by
the Dan David Foundation, although there is a relationship between it and Tel Aviv University
pursuant to which Tel Aviv provides space and administrative support for the award program.
Professor Rabinovich was the President of Tel Aviv University when Dan David began his Foundation
and an agreement was reached.  Professor Rabinovich confirmed that the Foundation could opt to
move the administrative headquarters of the Prize out of the University.
Upon review of the web site, you may also notice reference to French Collaboration.  The Dan David
Foundation entered into an agreement with the French Government in 2006.  Professor Rabinovich
has said that this was intended to further the international outreach efforts of the Foundation.  In
alternating years the Prize ceremony is held in France.  In exchange, two or three seats on the Dan
David Prize Board “belong” to the French.  The current composition of the Board is at:
http://www.dandavidprize.org/about/about-the-board.html .
 Released by Chairman Rand Paul
Based upon the available information, and in light of OLC’s opinions (particularly the more recent
award opinion covering the President’s Nobel Prize), I do not think the Dan David Prize implicates
the Emoluments Clause or the Foreign Gifts and Decorations Act.
Although Tel Aviv University is an NIH grantee, I do not think the Dan David Prize implicates our
Supplemental Standard because the Prize appears to be from the Dan David Foundation, a separate
entity that does not appear to be a grantee or otherwise have any business dealings with the NIH.
Moreover, although the recipient is expected to give a lecture (at a symposium, and in addition to
acceptance remarks during the presentation ceremony), the Dan David Prize appears to be a bona
fide award made as part of an established program of recognition that an NIH employee, including
Dr. Collins, might be permitted to accept (assuming no change in the program or other individualized
issue).  Again , the award appears to be from the Dan David Foundation.  I have found no record of
any business interactions between NIH and the Dan David Foundation, so OGE’s source limitation is
not an issue.  Although there is a symposium at which the recipients are expected to give a
presentation, I have been told they give talks about their work over the course of their careers,
rather than current science and theory, and $1 million is far outside of the range of typical honoraria
paid for individual presentations.  From videos available on the internet (at sites not presently
blocked by NIH security measures), it appears that the Prize ceremony is quite elaborate, well-
attended, and in keeping with what we expect such an event to “look like.”  Press reports that
coincide with the announcement of each year’s winners appear to reflect that this is a significant
award/honor.
Gretchen H. Weaver, J.D.
Supervisory/Senior NIH Ethics Counsel
DHHS/OGC/Ethics Division
phone:
fax:
NOTICE:  THIS E-MAIL MESSAGE FROM THE OFFICE OF THE GENERAL COUNSEL (OGC), ETHICS DIVISION IS INTENDED FOR THE EXCLUSIVE
USE OF THE RECIPIENT(S) NAMES ABOVE AND MAY CONTAIN PROTECTED, PRIVILEGED, OR CONFIDENTIAL INFORMATION THAT SHOULD
NOT BE TRANSMITTED TO UNAUTHORIZED ADDRESSEES.  IF YOU ARE NOT THE INTENDED RECIPIENT, ANY DISSEMINATION,
DISTRIBUTION, OR COPYING IS STRICTLY PROHIBITED.  IF YOU HAVE RECEIVED THIS E-MAIL IN ERROR, PLEASE NOTIFY THE SENDER
IMMEDIATELY AT THE ABOVE ADDRESS.  EMPLOYEE RECIPIENTS ARE COUNSELED THAT DISCIPLINARY ACTION FOR VIOLATING FEDERAL
ETHICS REGULATIONS MAY NOT BE TAKEN AGAINST ANY EMPLOYEE WHO HAS ENGAGED IN CONDUCT IN GOOD FAITH RELIANCE UPON
THE PRIOR ADVICE OF ANY AGENCY ETHICS OFFICIAL, PROVIDED THAT THE EMPLOYEE HAS MADE FULL DISCLOSURE OF ALL RELEVANT
CIRCUMSTANCES.  IF EMPLOYEE CONDUCT IS POTENTIALLY SUBJECT TO CRIMINAL SANCTIONS UNDER CONFLICT OF INTEREST AND
RELATED STATUTES, RELIANCE OF THE ADVICE OF AN AGENCY ETHICS OFFICIAL IN INTERPRETING THE SCOPE OF SUCH STATUTES IS A
FACTOR THAT MAY BE TAKEN INTO ACCOUNT BY THE DEPARTMENT OF JUSTICE IN EXERCISING PROSECUTORIAL DISCRETION.
EMPLOYEES ARE CAUTIONED THAT DISCLOSURES TO AN OGC ATTORNEY ARE NOT PROTTECTED WITHIN THE DEPARTMENT BY
ATTORNEY-CLIENT PRIVILEGE.  ALL EMPLOYEES, INCLUDING AGENCY ATTORNEYS, ARE REQUIRED TO REPORT CRIMINAL VIOLATIONS TO
THE OFFICE OF THE INSPECTOR GENERAL.
From:  Jaffe, Holli Beckerman (NIH/OD) [E] < @od.nih.gov >
Sent:  Friday, January 29, 2021 2:16 PM
LectureReleased by Chairman Rand Paul
Released by Chairman Rand Paul
Released by Chairman Rand Paul
From:"Conrad, Patricia (NIH/NIAID) [E]" < @niaid.nih.gov>To:"Fauci, Anthony (NIH/NIAID) [E]" < @niaid.nih.gov>Cc:"Folkers, Greg (NIH/NIAID) [E]" < @niaid.nih.gov>Subject:FW: DECISION: Anthony FAUCI's NIH 2854 approvedDate:Sat, 10 Apr 2021 11:52:15 -0400Importance:NormalCongratulations....you're rich!-----Original Message-----From: Bennett, Arthur (NIH/NIAID) [E] < @niaid.nih.gov>Sent: Friday, April 9, 2021 4:44 PMTo: Conrad, Patricia (NIH/NIAID) [E] < @niaid.nih.gov>Subject: FW: DECISION: Anthony FAUCI's NIH 2854 approvedAt last!!!!!!!-----Original Message-----From: NIHNEES < @mail.nih.gov>Sent: Friday, April 9, 2021 4:43 PMTo: Fauci, Anthony (NIH/NIAID) [E] < @niaid.nih.gov>; Bennett, Arthur (NIH/NIAID) [E]< @niaid.nih.gov>Cc: Bennett, Arthur (NIH/NIAID) [E] < @niaid.nih.gov>Subject: DECISION: Anthony FAUCI's NIH 2854 approvedSYSTEM-GENERATED MESSAGE; PLEASE DO NOT REPLY TO THIS MESSAGE VIA EMAIL.The  NIH 2854 for  Dan David Prize has been approved.Please go to https://nees.nih.gov and log in as employee/filer. Choose View the report, then click on the View/Print tab toopen the pdf  Request.Remember, you are recused from all specific party matters where the award donor organization is a party to the matter, forone year following the date you will receive the award. This means that you may not participate in any official Governmentmatter (e.g., grant or contract) in which the award donor is also a party (e.g., the grantee or contractor) until one yearfollowing the date you receive the award. If anyone attempts to discuss a Government matter involving the donororganization, please stop the discussion and refer the individual to your supervisor. If you have questions, contact your IC'sethics office. Contact information is available at http://ethics.od.nih.gov/coord.pdf. Released by Chairman Rand Paul
From:"Folkers, Greg (NIH/NIAID) [E]" < @niaid.nih.gov>To:"Conrad, Patricia (NIH/NIAID) [E]" < @niaid.nih.gov>Subject:RE: DECISION: Anthony FAUCI's NIH 2854 approvedDate:Sat, 10 Apr 2021 11:58:34 -0400Importance:NormalI want my 15% Released by Chairman Rand Paul
From:"Fauci, Anthony (NIH/NIAID) [E]" < @niaid.nih.gov>To:"Conrad, Patricia (NIH/NIAID) [E]" < @niaid.nih.gov>Subject:RE: DECISION: Anthony FAUCI's NIH 2854 approvedDate:Sat, 10 Apr 2021 16:43:40 -0400Importance:Normal -----Original Message-----From: Conrad, Patricia (NIH/NIAID) [E] < @niaid.nih.gov>Sent: Saturday, April 10, 2021 11:52 AMTo: Fauci, Anthony (NIH/NIAID) [E] < @niaid.nih.gov>Cc: Folkers, Greg (NIH/NIAID) [E] < @niaid.nih.gov>Subject: FW: DECISION: Anthony FAUCI's NIH 2854 approved Congratulations....you're rich!   -----Original Message-----From: Bennett, Arthur (NIH/NIAID) [E] <@niaid.nih.gov>Sent: Friday, April 9, 2021 4:44 PMTo: Conrad, Patricia (NIH/NIAID) [E] <@niaid.nih.gov>Subject: FW: DECISION: Anthony FAUCI's NIH 2854 approved At last!!!!!!! -----Original Message-----From: NIHNEES <@mail.nih.gov>Sent: Friday, April 9, 2021 4:43 PMTo: Fauci, Anthony (NIH/NIAID) [E] <@niaid.nih.gov>; Bennett, Arthur (NIH/NIAID) [E]<@niaid.nih.gov>Cc: Bennett, Arthur (NIH/NIAID) [E] <@niaid.nih.gov>Subject: DECISION: Anthony FAUCI's NIH 2854 approved SYSTEM-GENERATED MESSAGE; PLEASE DO NOT REPLY TO THIS MESSAGE VIA EMAIL.  The  NIH 2854 for  Dan David Prize has been approved.  Please go to https://nees.nih.gov and log in as employee/filer. Choose View the report, then click on theView/Print tab to open the pdf  Request.  Released by Chairman Rand Paul
Remember, you are recused from all specific party matters where the award donor organization is a party to thematter, for one year following the date you will receive the award. This means that you may not participate inany official Government matter (e.g., grant or contract) in which the award donor is also a party (e.g., thegrantee or contractor) until one year following the date you receive the award. If anyone attempts to discuss aGovernment matter involving the donor organization, please stop the discussion and refer the individual to yoursupervisor. If you have questions, contact your IC's ethics office. Contact information is available athttp://ethics.od.nih.gov/coord.pdf.Released by Chairman Rand Paul
  Released by Chairman Rand Paul
From:Dan David Prize < @tauex.tau.ac.il>To:" @niaid.nih.gov'" < @niaid.nih.gov>Subject:Dan David Prize - Bank TransferDate:Tue, 11 May 2021 06:13:57 -0400Importance:NormalAttachments:Watch_the_ceremony.3.pdf; Anthony_Fauci_-_Swift.pdfDear Dr. Fauci, I am attaching a copy of the bank transfer. Please confirm that you have received the funds. I am also attaching a flyer, with a link to ceremony screening. Best wishes,Tami Tami NoamProject CoordinatorDan David PrizeOffice: @tauex.tau.ac.ilEmail: www.dandavidprize.orgWebsite:   Released by Chairman Rand Paul
Released by Chairman Rand Paul
From:"Fauci, Anthony (NIH/NIAID) [E]" < @niaid.nih.gov>To:"Dan David Prize" < @tauex.tau.ac.il>Subject:RE: Dan David Prize - Bank TransferDate:Sat, 15 May 2021 13:54:55 -0400Importance:NormalI have received the funds.   Many thanks.Best regards,A.S. FauciAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesNational Institutes of HealthBethesda, MD Phone: FAX: E-mail: @niaid.nih.govThe information in this e-mail and any of its attachments is confidential and may contain sensitive information.  Itshould not be used by anyone who is not the original intended recipient.  If you have received this e-mail in errorplease inform the sender and delete it from your mailbox or any other storage devices.  The National Institute ofAllergy and Infectious Diseases (NIAID) shall not accept liability for any statements made that are the sender'sown and not expressly made on behalf of the NIAID by one of its representatives.  From: Dan David Prize < @tauex.tau.ac.il>Sent: Tuesday, May 11, 2021 6:14 AMTo: Fauci, Anthony (NIH/NIAID) [E] < @niaid.nih.gov>Subject: Dan David Prize - Bank Transfer Dear Dr. Fauci, I am attaching a copy of the bank transfer. Please confirm that you have received the funds. I am also attaching a flyer, with a link to ceremony screening. Best wishes,Tami Tami NoamProject CoordinatorDan David PrizeOffice: @tauex.tau.ac.ilEmail: www.dandavidprize.orgWebsite:   Released by Chairman Rand Paul
From:"Fauci, Anthony (NIH/NIAID) [E]" < @niaid.nih.gov>To:"Folkers, Greg (NIH/NIAID) [E]" < @niaid.nih.gov>Cc:"Conrad, Patricia (NIH/NIAID) [E]" < @niaid.nih.gov>, "Auchincloss, Hugh(NIH/NIAID) [E]" <@niaid.nih.gov>, "Barasch, Kimberly (NIH/NIAID) [E]"<@nih.gov>Subject:RE: Dinarello has a questionDate:Mon, 23 Aug 2021 16:25:22 -0400Importance:NormalInline-Images:image002.jpgI did not want Bart  to nominate me for the Shaw Prize.   If Charles wants me to nominate himfor the Shaw Prize, I would be happy to do so.   He would have to write the nomination as hehas done in the past. Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesNational Institutes of HealthBethesda, MD Phone: FAX: E-mail: @niaid.nih.govThe information in this e-mail and any of its attachments is confidential and may contain sensitive information.  Itshould not be used by anyone who is not the original intended recipient.  If you have received this e-mail in errorplease inform the sender and delete it from your mailbox or any other storage devices.  The National Institute ofAllergy and Infectious Diseases (NIAID) shall not accept liability for any statements made that are the sender'sown and not expressly made on behalf of the NIAID by one of its representatives.  From: Folkers, Greg (NIH/NIAID) [E] < @niaid.nih.gov>Sent: Monday, August 23, 2021 3:25 PMTo: Fauci, Anthony (NIH/NIAID) [E] < @niaid.nih.gov>Cc: Conrad, Patricia (NIH/NIAID) [E] < @niaid.nih.gov>; Auchincloss, Hugh (NIH/NIAID) [E]<@niaid.nih.gov>; Barasch, Kimberly (NIH/NIAID) [E] <@nih.gov>Subject: RE: Dinarello has a question This came to BartHe asked you if you wanted him to nominate you Don’t know where that stands, nor what to do re: charles  From: Barton Haynes, M.D. <@duke.edu>Sent: Sunday, November 15, 2020 10:01 PMTo: Conrad, Patricia (NIH/NIAID) [E] <@niaid.nih.gov>; Anthony Fauci [E] <@gmail.com>; Fauci, Anthony(NIH/NIAID) [E] <@niaid.nih.gov>Cc: Kelly Soderberg <@duke.edu>Subject: Fwd: Final Reminder to Nominate a Candidate for The Shaw Prize in Life Science and Medicine 2021Released by Chairman Rand Paul
   Hi TonyHave you won this yet? Want me to nominate you? Best bSent from my iPhone  From: The Shaw Prize <@shawprize.org>Date: November 15, 2020 at 9:50:51 PM ESTTo: "Barton Haynes, M.D." <@duke.edu>Subject: Final Reminder to Nominate a Candidate for The Shaw Prize in Life Science and Medicine 2021
The Shaw PrizeDear Professor Barton F Haynes,This letter serves as our renewed invitation to you to nominate a candidate for The Shaw Prize in Life Science andMedicine.Please click on the link below to start the nomination process. If this is your first visit to this new round of 2021, you willbe invited to set a password before you begin.BEGIN NOMINATIONPlease treat this invitation and nomination as highly confidential and kindly do not transfer the invitation for nominationto any other individual.Thank you for your support and please note that all nominations must be received by the Shaw Prize on or before 30November 2020. Sincerely yours,Peggy NgThe Shaw Prize Secretariat   From: Fauci, Anthony (NIH/NIAID) [E] <@niaid.nih.gov>Sent: Monday, August 23, 2021 11:39 AMTo: Folkers, Greg (NIH/NIAID) [E] <@niaid.nih.gov>Cc: Conrad, Patricia (NIH/NIAID) [E] <@niaid.nih.gov>; Auchincloss, Hugh (NIH/NIAID) [E]<@niaid.nih.gov>; Barasch, Kimberly (NIH/NIAID) [E] <@nih.gov>Subject: Re: Dinarello has a question Greg: I believe I have been asked by the Shaw prize people to nominate someone. However because I have been so busy Ijust discarded the request and no longer have the forms. I am not sure whether I can get another copy since I believe thatCharles wants me to nominate him. Let us discuss. Thanks, Tony Released by Chairman Rand Paul
On Aug 23, 2021, at 11:25 AM, Folkers, Greg (NIH/NIAID) [E] <@niaid.nih.gov> wrote:Do u know? From: charles dinarello <@aol.com>Sent: Monday, August 23, 2021 11:24 AMTo: Folkers, Greg (NIH/NIAID) [E] <@niaid.nih.gov>Subject: Dinarello has a question I thoroughly enjoyed Tony's acceptance speech for the Dan David Prize and again I thank you for your essential  role inthe nomination process.  Can you find out if Tony has been asked by the Shaw Prize committee to nominate someone.Thanks. CharlesReleased by Chairman Rand Paul
From:"Miller, Katherine (NIH/NIAID) [E]" < @niaid.nih.gov>To:"Auchincloss, Hugh (NIH/NIAID) [E]" <@niaid.nih.gov>Cc:"Holland, Steven (NIH/NIAID) [E]" < @niaid.nih.gov>, "Shaffer, Meredith(NIH/NIAID) [E]" <@nih.gov>Subject:RE: Nominate Anthony Fauci as an exceptional candidate in infectious diseases for the 2022John J. Carty Award for the Advancement of ScienceDate:Fri, 17 Sep 2021 09:50:23 -0400Importance:NormalThank you! From: Auchincloss, Hugh (NIH/NIAID) [E] <@niaid.nih.gov>Sent: Friday, September 17, 2021 9:40 AMTo: Miller, Katherine (NIH/NIAID) [E] < @niaid.nih.gov>Cc: Holland, Steven (NIH/NIAID) [E] < @niaid.nih.gov>; Shaffer, Meredith (NIH/NIAID) [E]<@nih.gov>Subject: RE: Nominate Anthony Fauci as an exceptional candidate in infectious diseases for the 2022 John J. Carty Awardfor the Advancement of Science You could ask Laurie Glimcher     @dfci.harvard.edu and Larry Corey  @fredhutch.org From: Miller, Katherine (NIH/NIAID) [E] <@niaid.nih.gov>Sent: Thursday, September 16, 2021 4:55 PMTo: Auchincloss, Hugh (NIH/NIAID) [E] <@niaid.nih.gov>Cc: Holland, Steven (NIH/NIAID) [E] <@niaid.nih.gov>; Shaffer, Meredith (NIH/NIAID) [E]<@nih.gov>Subject: FW: Nominate Anthony Fauci as an exceptional candidate in infectious diseases for the 2022 John J. Carty Awardfor the Advancement of Science Hi HughHow are you?  I hope you are doing well in these extraordinary times. Steve has asked that I help with the nomination of Dr. Fauci for the Carty award.  The timeline is tight and the mostimmediate concern is the need for two reference letters from outside NIH (highlight below).  I am happy to solicit theletters – have referees been identified?I will also draft a letter and citation to send through the usual channels for review and I’ll reach out to Greg for theabbreviated CV and top 12 publications unless you advise an alternative course.Thank you and take care.Best,Katherine  From: Estes, Mary Kolb <@bcm.edu>Sent: Monday, September 13, 2021 11:55 AMTo: Collins, Francis (NIH/OD) [E] <@od.nih.gov>Subject: Nominate Anthony Fauci as an exceptional candidate in infectious diseases for the 2022 John J. CartyAward for the Advancement of Science  Dear Francis,Released by Chairman Rand Paul
 I am chairing the committee to review nominees for the 2022 John J. Carty Award for the Advancementof Science that will be presented at the National Academy of Sciences meeting next spring. The committee easily identify Dr. Fauci as an exceptional candidate for this award.  I am writing ask ifyou would be willing and able to nominate him for this Award. The 2022 John J. Carty Award recognizes noteworthy and distinguished accomplishments in infectiousdiseases. The award is presented with a medal and a $25,000 prize. Additional information, includingpast recipients, eligibility requirements, and more, can be found at http://bit.ly/NASCartyAward. All nominations must be submitted online. Unless otherwise stated, the following materials must besubmitted: 1. A letter from the nominator describing the candidate's work and why he or she should be selected forthe award. No more than three (3) pages.2. Curriculum vitae. No more than two (2) pages (similar to CVs included with NSF proposals but other 2page formats are acceptable).3. Bibliography listing no more than twelve (12) of the nominee's most significant publications.4. Suggested citation. A 50-word summary stating why the nominee should be considered for thisaward. Citation examples»5. Two letters of support. Support letters must be written by individuals from institutions outside boththe nominator's and the nominee’s institution. Nominations accepted through Monday, October 4, 2021. Please let me know if your office can do this or if you have another suggestion for who I might contact.   Thank you and I look forward to hearing from you. Sincerely, Mary Mary K. Estes, PhDThe Carty Award Selection Committee Distinguished Service ProfessorDepartment of Molecular Virology and MicrobiologyBaylor College of MedicineHouston, Texas  cell Released by Chairman Rand Paul
From:"/O=EXCHANGELABS/OU=EXCHANGE ADMINISTRATIVE GROUP(FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=DF38103D75134F658AE2D356F0396B94-AFAUCI" < @niaid.nih.gov>To:"Conrad, Patricia (NIH/NIAID) [E]" < @niaid.nih.gov>, "Bennett, Arthur(NIH/NIAID) [E]" < @niaid.nih.gov>Cc:"Barasch, Kimberly (NIH/NIAID) [E]" <@nih.gov>Subject:RE: Draft info - Dr. Fauci annual financial disclosure reportDate:Wed, 23 Mar 2022 11:20:59 -0400Importance:NormalInline-Images:image001.pngArthur:    Some corrections to you e-mail regarding gifts, awards, etc.:1. The Dan David prize that was deposited in my bank account was $899,960. 00, not $901,400.2) The Elliot Richardson Prize was officially $25,000.00; however, I only received $12,500since they automatically gave $!2,500 of the $25,000 to charity.   That was a condition of theaward. 3) My wife and I never attended the Amethyste at the French Ambassador’s home.  We were invited, but we did not attend.Thanks,Tony Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesNational Institutes of HealthBethesda, MD Phone: FAX: E-mail:@niaid.nih.govThe information in this e-mail and any of its attachments is confidential and may contain sensitive information.  Itshould not be used by anyone who is not the original intended recipient.  If you have received this e-mail in errorplease inform the sender and delete it from your mailbox or any other storage devices.  The National Institute ofAllergy and Infectious Diseases (NIAID) shall not accept liability for any statements made that are the sender'sown and not expressly made on behalf of the NIAID by one of its representatives.  From: Conrad, Patricia (NIH/NIAID) [E] < @niaid.nih.gov>Sent: Wednesday, March 23, 2022 11:11 AMTo: Bennett, Arthur (NIH/NIAID) [E] < @niaid.nih.gov>Cc: Barasch, Kimberly (NIH/NIAID) [E] <@nih.gov>; Fauci, Anthony (NIH/NIAID) [E]< @niaid.nih.gov>Subject: Re: Draft info - Dr. Fauci annual financial disclosure report Thanks u. Adding ASF Sent from my iPhoneReleased by Chairman Rand Paul
Released by Chairman Rand Paul

Summary:
Watcher-discovered document from paul-readingroom (7.24.2026_Fauci-Awards_FINAL_REDACTED.pdf), auto-indexed 2026-07-27.

Excerpt: for Drs. Fauci and Rosenberg.  https://www.dandavidprize.org/prize/prize-nominations Linda D. Simmons   NIH Ethics Office (NEO) National Institutes of Health Bethesda, MD  @nih.gov  (NEO)  (direct) https://ethics.od.nih.gov    Released by Chairman Rand Paul From:  Weaver, Gretchen (NIH/OD) [E] < @od.nih.gov >  Sent:  Friday, January 29, 2021 3:18 PM To: Jaffe, Holli Beckerman (NIH/OD) [E] < @od.nih.gov > Subject:  RE: Dan David Prize   Holli:  Here is discussion from 2011.  If you can confirm that nothing has changed, including the “attendant events” that are now mentioned on the web site, this should be helpful.  I did all of the leg work.  Ed took this information to OGE and OGE accepted the award as bona fide even though the subject area to be recognized changes, etc.:     The Dan…


HERE

Released by Chairman Rand Paul
Released by Chairman Rand Paul
Released by Chairman Rand Paul
Released by Chairman Rand Paul
Released by Chairman Rand Paul
Photos
#Preview
1.
2.
Date of Birth
1.DASZAK, PETERPlace of Birth
1.Place of Birth:DUKINFIELD
UNITED KINGDOM GB/GBR
City:DUKINFIELD
Country:United Kingdom (GB/GBR)
2.Country:United Kingdom (GB/GBR)
Citizenship
United States (US/USA)
Disposition
1.Disposition Category:
Disposition: ActionUNCLASSIFIED//LES
UNCLASSIFIED//LES
Released by Chairman Rand Paul
Disposition Reason
1.Remarks:Referred to .  FBI requested not to stop subject.  No further
NTC action
Records
#Person Record Name S
ubtype Record ID Code
1.
2.PNR
3.PNR
4.TECS
Conveyances
1.MOT:Air-Commercial
Est Departure:01/12/2021 01:00:00 EST
Est Arrival:01/12/2021 13:15:00 EST
Flight No:704
Carrier:QATAR AIRWAYS (QR)
F
rom Port:John F Kennedy International Airport (JFK)
To Port:Hamad International Airport (DOH)
Itinerary Description: John F Kennedy International Airport(JFK)-Hamad International Airport(DOH)
2.MOT:Air-Commercial
Est Departure:02/04/2021 13:00:00 EST
Est Arrival:02/04/2021 21:30:00 EST
Flight No:945UNCLASSIFIED//LES
UNCLASSIFIED//LES
Released by Chairman Rand Paul
Carrier:QATAR AIRWAYS (QR)
From Port:Singapore Changi Airport (SIN)
To Port:Hamad International Airport (DOH)
Itinerary
Description:Singapore Changi Airport(SIN)-Hamad International Airport(DOH); Hamad
International Airport(DOH)-Singapore Changi Airport(SIN); Hamad
International Airport(DOH)-John F Kennedy International Airport(JFK)
3.MOT:Air-Commercial
Est Departure:01/12/2021 18:10:00 EST
Est Arrival:01/13/2021 01:55:00 EST
Flight No:946
Carrier:QATAR AIRWAYS (QR)
F
rom Port:Hamad International Airport (DOH)
To Port:Singapore Changi Airport (SIN)
Itinerary
Description:Singapore Changi Airport(SIN)-Hamad International Airport(DOH); Hamad
International Airport(DOH)-Singapore Changi Airport(SIN); Hamad
International Airport(DOH)-John F Kennedy International Airport(JFK)
4.MOT:Air-Commercial
Est Departure:02/05/2021 00:15:00 EST
Est Arrival:02/05/2021 14:25:00 EST
Flight No:701
Carrier:QATAR AIRWAYS (QR)
F
rom Port:Hamad International Airport (DOH)
To Port:John F Kennedy International Airport (JFK)
Itinerary
Description:Singapore Changi Airport(SIN)-Hamad International Airport(DOH); Hamad
International Airport(DOH)-Singapore Changi Airport(SIN); Hamad
International Airport(DOH)-John F Kennedy International Airport(JFK)
5.MOT:Air-Commercial
Est Departure:01/04/2021 21:00:00 EST
Est Arrival:01/05/2021 09:15:00 EST
Flight No:QR 702
Carrier:QATAR AIRWAYS (QR)
F
rom Port:John F Kennedy International Airport (JFK)
To Port:Hamad International Airport (DOH)
Itinerary
Description:John F Kennedy International Airport(JFK)-Hamad International Airport(DOH);
Hamad International Airport(DOH)-Singapore Changi Airport(SIN); Singapore
Changi Airport(SIN)-San Francisco International Airport(SFO); San Francisco
International Airport(SFO)-Newark Liberty International Airport(EWR)
6.MOT:Air-Commercial
Est Departure:01/05/2021 12:30:00 EST
Est Arrival:12/31/1969 20:45:00 EST
Flight No:QR 942
Carrier:QATAR AIRWAYS (QR)
F
rom Port:Hamad International Airport (DOH)
To Port:Singapore Changi Airport (SIN)
Itinerary
Description:John F Kennedy International Airport(JFK)-Hamad International Airport(DOH);
Hamad International Airport(DOH)-Singapore Changi Airport(SIN); Singapore
Changi Airport(SIN)-San Francisco International Airport(SFO); San Francisco
International Airport(SFO)-Newark Liberty International Airport(EWR)
7.MOT:Air-Commercial
Est Departure:02/04/2021 21:00:00 EST
Est Arrival:01/01/1970 11:35:00 ESTUNCLASSIFIED//LES
UNCLASSIFIED//LES
Released by Chairman Rand Paul
Flight No:UA 2
Carrier:UNITED AIRLINES (UA)
From Port:Singapore Changi Airport (SIN)
To Port:San Francisco International Airport (SFO)
Itinerary
Description:John F Kennedy International Airport(JFK)-Hamad International Airport(DOH);
Hamad International Airport(DOH)-Singapore Changi Airport(SIN); Singapore
Changi Airport(SIN)-San Francisco International Airport(SFO); San Francisco
International Airport(SFO)-Newark Liberty International Airport(EWR)
8.MOT:Air-Commercial
Est Departure:02/05/2021 13:45:00 EST
Est Arrival:01/01/1970 19:23:00 EST
Flight No:UA 1900
Carrier:UNITED AIRLINES (UA)
F
rom Port:San Francisco International Airport (SFO)
To Port:Newark Liberty International Airport (EWR)
Itinerary
Description:John F Kennedy International Airport(JFK)-Hamad International Airport(DOH);
Hamad International Airport(DOH)-Singapore Changi Airport(SIN); Singapore
Changi Airport(SIN)-San Francisco International Airport(SFO); San Francisco
International Airport(SFO)-Newark Liberty International Airport(EWR)
Activity Reason
GLOBAL TACTICAL OPERATIONS BRANCHUNCLASSIFIED//LES
UNCLASSIFIED//LES
Released by Chairman Rand Paul
Activity Remarks
Re
m
ar
k
Ty
peRemark
RE
MA
RK* DASZAK was asked publicly by NIH to retrieve the original type-specimen used by WIV for
genetic analysis, and return it to the United States.  He was also asked to explain several
aspects of their collaboration, including related to cell phone data.  DASZAK called the
requirements "outrageous" and does not appear to intend to comply with them
(https://www.sciencemag.org/news/2020/08/nih-imposes-outrageous-conditions-resuming-coronavirus-
grant-targeted-trump)
* DASZAK and EcoHealth has been awarded a number of contracts and grants from the U.S.
federal government.  These include contracts with the DHS Chemical and Biological Threat
Division.  Many items that EcoHealth studies are likely to be subject to serious non-disclosure
agreements with the U.S. government and/or be export controlled.
More background information in the kind of research that DASZAK is heavily involved in.  A lot of
the funding DASZAK receives is put towards "gain of function research" also known as biological
weapons research.  This research involves experimentation that aims or is expected to increase
the transmissibility and/or virulence of pathogens. Such research, when conducted by responsible
scientists, usually aims to improve understanding of disease causing agents, their interaction
with human hosts, and/or their potential to cause pandemics. The ultimate objective of such
research is to better inform public health and preparedness efforts and/or development of medical
countermeasures.  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996883/  In gain of function
research, genome sequences are reconstructed/reformulated and are inserted into human/animal
cells to be studied on how the "new" sequence effects humans and/or animals.  There is a lot of
criticism on gain of function research in regards to ethics and if the science is worth the risks
of creating a potentially harmful virus or disease.
In 2013, DASZAK was a coauthor of publication "Isolation and characterization of a bat SARS-like
coronavirus that uses the ACE2 receptor" with Zhengli SHI and Ralph BARIC.  This paper is of
significance due to the first reporting of a SL-CoV-WIV1 (SARS-like coronavirus WIV1) binding to
human cells and infecting them.  https://www.nature.com/articles/nature12711#Sec2  Essentially,
DASZAK and collaborators at WIV created a bat coronavirus capable of directly infecting humans.
A follow up article published in Nature magazine on 12/12/2015 titled "Engineered bat virus stirs
debate over risky research, Lab-made coronavirus related to SARS can infect human cells" debates
"whether engineering lab variants of viruses with possible pandemic potential is worth the
risks." https://www.nature.com/news/engineered-bat-virus-stirs-debate-over-risky-research-
%201.18787
During the inspection, it is hard to say if DASZAK will be forthcoming with information.UNCLASSIFIED//LES
UNCLASSIFIED//LES
Released by Chairman Rand Paul
Re
m
ar
k
Ty
peRemark
RE
MA
RKFrom: CBP.DHS.GOV>
Sent: Tuesday, February 2, 2021 10:18 PM
To: cbp.dhs.gov>
Cc:  REFERRALS cbp.dhs.gov>; S
@cbp.dhs.gov>
Subject: Re: Subject Event 3  P. DASZAK C
10-4, thanks. We'll send it out in the morning.
Charlie
Sent from my iPhone
On Feb 2, 2021, at 10:11 PM, cbp.dhs.gov> wrote:

Good evening ,

***FYSA - NTC has rescinded previous inspection request; however, subject may be of interest to
the FBI ***

Peter DASZAK  (DOB:  is scheduled to travel from DOH to JFK on
02/05/2021, aboard QR #701 ETA 1425 EST- Event has been created for additional
information.

*** Reference event for notable publications and news articles.***

Background
Peter DASZAK (DOB: is the President of EcoHealth
Alliance; a US science-based non-profit that conducts research and outreach on the causes of
emerging pandemic diseases, and their links to environmental change and conservation (Link).
DASZAK's scientific research is focused on understanding the drivers of emerging diseases to
include: evidence that emerging disease, chytridiomycosis, causes global amphibian declines; the
first ever map of emerging disease 'hotspots'; and the identification of bats as a reservoir for
SARS.  DASZAK's goals are to understand what drives disease emergence develop innovative ways to
stop emerging diseases in wildlife, livestock and people; and promote conservation of wildlife.

DASZAK, is part of the World Health Organization (WHO) team that is investigating the origins of
SARS-CoV-2, the virus that causes COVID-19 (Link).  DASZAK is also affiliated with Zhengli SHI
(Bat Woman) - the lead Virologist and Researcher at the Wuhan Institute of Virology (WIV),
Chinese Academy of Sciences (CAS) Link. SHI's areas of study include:  Bats, Viral Ecology, Viral
Entry, Virus Discovery, Zoonotic Diseases, Virology, Ecology of Pathogens (Link). EcoHealth

Alliance and DASZAK have been working with Shi Zhengli for more than 15 years.

DASZAK is listed as the Principal Investigator (PI) on National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID) grants:  1U01AI151797-01 -
Understanding Risk of Zoonotic Viruses Emergence in EID Hotspots of Southeast Asia, and
#2R01AI110964-06:  Understanding the Risk of Bat Coronavirus Emergence, dated  6/01/2014-
06/30/2024.  SHI listed grant R01AI110964 on her resume (Link), although SHI is not listed as a
PI.  A search of the grant revealed 19 publications (Link), many of which were written by SHI.

Additional information
* DASZAK was asked publicly by NIH to retrieve the original type-specimen used by WIV for
genetic analysis, and return it to the United States. He was also asked to explain several UNCLASSIFIED//LES
UNCLASSIFIED//LES
Released by Chairman Rand Paul

Re
m
ar
k
Ty
peRemarkaspects of their collaboration, including related to cell phone data. Link
* DASZAK and EcoHealth has been awarded a number of contracts and grants from the U.S.
federal government. These include contracts with the DHS Chemical and Biological Threat Division.
Many items that EcoHealth studies are likely to be subject to serious non-disclosure agreements
with the U.S. government and/or be export controlled.

* Much of the funding DASZAK receives is put towards gain of function research.  This
research involves experimentation that aims or is expected to increase the transmissibility

and/or virulence of pathogens. The ultimate objective of such research is to better inform public
health and preparedness efforts and/or development of medical countermeasures. Link

* In 2013, DASZAK was a coauthor of publication "Isolation and characterization of a bat
SARS-like coronavirus that uses the ACE2 receptor" with Zhengli SHI and Ralph BARIC. This paper
is of significance due to the first reporting of a SL-CoV-WIV1 (SARS-like coronavirus WIV1)
binding to human cells and infecting them. Link

* A follow up article published in Nature magazine on 12/12/2015 titled "Engineered bat
virus stirs debate over risky research, Lab-made coronavirus related to SARS can infect human
cells" debates "whether engineering lab variants of viruses with possible pandemic potential is
worth the risks." Link

Respectfully,

National Targeting Security Specialist
National Targeting Center (NTC)
Tactical Targeting

WARNING:  This document is LAW ENFORCEMENT SENSITIVE and is designated for OFFICIAL USE ONLY.  It
contains information that may be exempt from public release under the Freedom of Information Act
(5USC552). This document is to be controlled, handled, transmitted, distributed, and disposed of
in accordance with DHS policy relating to FOUO information, and is not to be released to the
public or personnel who do not have a valid "need-to-know" without prior approval from OFO
National Targeting Center - Passenger at 571-468-1000.UNCLASSIFIED//LES
UNCLASSIFIED//LES
Released by Chairman Rand Paul
Re
m
ar
k
Ty
peRemark
RE
MA
RKFrom: cbp.dhs.gov>
Sent: Tuesday, February 2, 2021 8:55 PM
To: cbp.dhs.gov>; J bp.dhs.gov>; NY
REFERRALS cbp.dhs.gov>
Cc: NTC-P cbp.dhs.gov>; P
@cbp.dhs.gov>
Subject: RE: Referral Event 3  P. DASZAK C
10/4
Supervisory Officer- TTRT
US Customs and Border Protection
From: cbp.dhs.gov>
Sent: Tuesday, February 2, 2021 8:49 PM
To: cbp.dhs.gov>; N REFERRALS < bp.dhs.gov>
Cc: NTC-P NatSec Group cbp.dhs.gov>; P
@cbp.dhs.gov>
Subject:  Referral Event 3  P. DASZAK C
Good afternoon,
Please consider the following subject for a TTRT Exam.
Peter DASZAK  (DOB:  is scheduled to travel from DOH to JFK on
02/05/2021, aboard QR #701 ETA 1425 EST- Event has been created for additional
information.
*** Reference event for notable publications and news articles.***
Background
Peter DASZAK (DOB: is the President of EcoHealth
Alliance; a US science-based non-profit that conducts research and outreach on the causes of
emerging pandemic diseases, and their links to environmental change and conservation (Link).
DASZAK's scientific research is focused on understanding the drivers of emerging diseases to
include: evidence that emerging disease, chytridiomycosis, causes global amphibian declines; the
first ever map of emerging disease 'hotspots'; and the identification of bats as a reservoir for
SARS.  DASZAK's goals are to understand what drives disease emergence develop innovative ways to
stop emerging diseases in wildlife, livestock and people; and promote conservation of wildlife.
DASZAK, is part of the World Health Organization (WHO) team that is investigating the origins of
SARS-CoV-2, the virus that causes COVID-19 (Link).  DASZAK is also affiliated with Zhengli SHI
(Bat Woman) - the lead Virologist and Researcher at the Wuhan Institute of Virology (WIV),
Chinese Academy of Sciences (CAS) Link. SHI's areas of study include:  Bats, Viral Ecology, Viral
Entry, Virus Discovery, Zoonotic Diseases, Virology, Ecology of Pathogens (Link). EcoHealth

Alliance and DASZAK have been working with Shi Zhengli for more than 15 years.UNCLASSIFIED//LES
UNCLASSIFIED//LES
Released by Chairman Rand Paul
Re
m
ar
k
Ty
peRemark
DASZAK is listed as the Principal Investigator (PI) on National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID) grants:  1U01AI151797-01 -
Understanding Risk of Zoonotic Viruses Emergence in EID Hotspots of Southeast Asia, and
#2R01AI110964-06:  Understanding the Risk of Bat Coronavirus Emergence, dated  6/01/2014-
06/30/2024.  SHI listed grant R01AI110964 on her resume (Link), although SHI is not listed as a
PI.  A search of the grant revealed 19 publications (Link), many of which were written by SHI.
Additional information
* DASZAK was asked publicly by NIH to retrieve the original type-specimen used by WIV for
genetic analysis, and return it to the United States. He was also asked to explain several
aspects of their collaboration, including related to cell phone data. Link
* DASZAK and EcoHealth has been awarded a number of contracts and grants from the U.S.

federal government. These include contracts with the DHS Chemical and Biological Threat Division.
Many items that EcoHealth studies are likely to be subject to serious non-disclosure agreements
with the U.S. government and/or be export controlled.
* Much of the funding DASZAK receives is put towards gain of function research.  This
research involves experimentation that aims or is expected to increase the transmissibility
and/or virulence of pathogens. The ultimate objective of such research is to better inform public
health and preparedness efforts and/or development of medical countermeasures. Link
* In 2013, DASZAK was a coauthor of publication "Isolation and characterization of a bat
SARS-like coronavirus that uses the ACE2 receptor" with Zhengli SHI and Ralph BARIC. This paper
is of significance due to the first reporting of a SL-CoV-WIV1 (SARS-like coronavirus WIV1)
binding to human cells and infecting them. Link
* A follow up article published in Nature magazine on 12/12/2015 titled "Engineered bat
virus stirs debate over risky research, Lab-made coronavirus related to SARS can infect human
cells" debates "whether engineering lab variants of viruses with possible pandemic potential is
worth the risks." Link
NTC Requests
* TTRT exam to include review of media (search level determined by POE).
* Why was DASZAK chosen to be on the WHO investigative team?
* Where in China did DASZAK go?
* Where did DASZAK stay while in China?
* Who was the POC?
* Did the team visit WIV? If so, what areas did they inspect? Who did the team meet with?
* Did the team visit the Chinese Center for Disease Control and Prevention? If so, what
areas did they inspect? Who did the team meet with?
* Did the team meet with any other officials from the Chinese government?
* Did DASZAK collect any biological samples during the trip?
* Is DASZAK traveling with any biological samples?
* Did he mail any samples back to the US?
* Did he take any materials with him to China?
* Has DASZAK maintained contact with anyone at the WIV? If so, whom and how often would he
communicate?  What do they communicate about?
* What was the purpose of DASZAK's travel from 01/04/2021-01/07/2021?
Respectfully,
National Targeting Security Specialist
National Targeting Center (NTC)UNCLASSIFIED//LES
UNCLASSIFIED//LES
Released by Chairman Rand Paul
Re
m
ar
k
Ty
peRemarkTactical Targeting
UNCLASS:
HSDN:
JWICS:
Phone:
WARNING:  This document is LAW ENFORCEMENT SENSITIVE and is designated for OFFICIAL USE ONLY.  It
contains information that may be exempt from public release under the Freedom of Information Act
(5USC552). This document is to be controlled, handled, transmitted, distributed, and disposed of
in accordance with DHS policy relating to FOUO information, and is not to be released to the
public or personnel who do not have a valid "need-to-know" without prior approval from OFO
National Targeting Center - Passenger at 571-468-1000.UNCLASSIFIED//LES
UNCLASSIFIED//LES
Released by Chairman Rand Paul
Re
m
ar
k
Ty
peRemark
RE
MA
RKHey ,
Do you have additional information besides this?
Peter DASZAK
* President of EcoHealth Alliance - US based non-profit organization that conducts research
and outreach programs on global health, conservation and international development//collaborates
with scientists around the world to discover new viruses in wildlife
https://www.scientificamerican.com/article/how-chinas-bat-woman-hunted-down-viruses-from-sars-to-
the-new-coronavirus1/ // https://www.ecohealthalliance.org/
* Listed as the Principle Investigator on National Institute of Health (NIH) National
Institute of Allergy and Infectious Diseases (NIAID) grant #2R01AI110964-06 "Understanding the
Risk of Bat Coronavirus Emergence" data indicates project dates 06/01/2014-06/30/2024 (Shi listed
this grant on her resume and is not a PI)
*
A search this grant revealed 19 publications  https://www.ncbi.nlm.nih.gov/pubmed?
term=R01+AI110964/AI/NIAID+NIH+HHS/United+States[Grant+Number]
o Articles of interest
* Origin and evolution of pathogenic coronaviruses Nature Reviews Microbiology volume 17,
pages181-192(2019) Authors - Jie Cui, Fang Li & Zheng-Li Shi This work was jointly funded by the
Strategic Priority Research Program of the Chinese Academy of Sciences (XDB29010000), the
National Natural Science Foundation of China (31621061) and the US National Institutes of Health
(NIH) National Institute of Allergy and Infection Diseases (R01AI110964) to Z.-L.S; NIH grants
(R01AI089728 and R01AI110700) to F.L.; the CAS Pioneer Hundred Talents Program to J.C.; and the
Wuhan Institute of Virology (WIV) "One-Three-Five" Strategic Program (WIV-135-TP1) to J.C. and
Z.-L.S
* Discovery of Novel Bat Coronaviruses in South China That Use the Same Receptor as Middle
East Respiratory Syndrome Coronavirus Journal of Virology Jun 2018, 92 (13) e00116-18 Authors -
Chu-Ming Luo, Ning Wang, Xing-Lou Yang, Hai-Zhou Liu, Wei Zhang, Bei Li, Ben Hu, Cheng Peng, Qi-
Bin Geng, Guang-Jian Zhu, Fang Li, Zheng-Li Shi This study was jointly funded by the Scientific
and Technological Basis Special Project (2013FY113500) from the Ministry of Science and
Technology of the People's Republic of China to Z.-L.S., a USAID Emerging Pandemic Threats
PREDICT project grant (Cooperative Agreement no. AID-OAA-A-14-00102), NIH grants (R01AI110964 to
Z.-L.S.; R01AI089728 and R01AI110700 to F.L.), and the National Natural Science Foundation of
China (31727901) to Z.-L.S.
* Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like
coronaviruses Science China Life Sciences volume 60, pages 1399-1402 (2017) Authors -Lei-Ping
Zeng, Xing-Yi Ge, Cheng Peng, Wanbo Tai, Shibo Jiang, Lanying Du & Zheng-Li Shi  In the
acknowledge section "This work was supported by the National Natural Science Foundation of China
(81290341, 31621061 to Zheng-Li Shi), the Strategic Priority Research Program of the Chinese
Academy of Sciences (XDPB0301 to Zheng-Li Shi), National Institute of Allergy and Infectious
Diseases of National Institutes of Health grant (R01AI110964 to Zheng-Li Shi), the National Key
Research and Development Program of China (2016YFC1201000 to Shibo Jiang) and NIH grant
(R01AI098775 to Shibo Jiang and Lanying Du)"
* Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights
into the origin of SARS coronavirus PLoS Pathog. 2017 Nov; 13(11): e1006698 Authors - Ben Hu,
Lei-Ping Zeng, Xing-Lou Yang, Xing-Yi Ge, Wei Zhang, Bei Li, Jia-Zheng Xie, Xu-Rui Shen, Yun-Zhi
Zhang, Ning Wang, Dong-Sheng Luo, Xiao-Shuang Zheng, Mei-Niang Wang, Peter Daszak, Lin-Fa Wang,
Jie Cui, Zheng-Li Shi
* Serological Evidence of Bat SARS-Related Coronavirus Infection in Humans, China
Virologica Sinica volume 33, pages104-107(2018) Authors - Ning Wang, Shi-Yue Li, Xing-Lou Yang,
Hui-Min Huang, Yu-Ji Zhang, Hua Guo, Chu-Ming Luo, Maureen Miller, Guangjian Zhu, Aleksei A.
Chmura, Emily Hagan, Ji-Hua Zhou, Yun-Zhi Zhang, Lin-Fa Wang, Peter Daszak & Zheng-Li Shi This
study was jointly funded by the National Natural Science Foundation of China Grant (81290341) to
ZLS; the National Institute of Allergy and Infectious Diseases of the National Institutes of
Health (Award Number R01AI110964) to PD and ZLS, United States Agency for International
Development (USAID) Emerging Pandemic Threats PREDICT project Grant (Cooperative Agreement No. UNCLASSIFIED//LES
UNCLASSIFIED//LES
Released by Chairman Rand Paul
Released by Chairman Rand Paul
Released by Chairman Rand Paul
Re
m
ar
k
Ty
peRemarkUS Customs and Border ProtectionUNCLASSIFIED//LES
UNCLASSIFIED//LES
Released by Chairman Rand Paul
Re
m
ar
k
Ty
peRemark
RE
MA
RK

DASZAK@ECOHEALTHALLIANCE.ORG
Linkedin: https://www.linkedin.com/in/peter-daszak-93987665/
Eco Alliance: https://www.ecohealthalliance.org/
SHI Bio: https://www.ws-virology.org/dt_team/zhengli-shi/
SHI CV: https://www.ws-virology.org/wp-content/uploads/2017/11/Zhengli-Shi.pdf
Relevant News articles
https://www.scientificamerican.com/article/how-chinas-bat-woman-hunted-down-viruses-from-sars-to-
the-new-coronavirus1/
https://childrenshealthdefense.org/defender/conflicts-of-interest-taint-investigations-covid-
origins/
https://www.sciencemag.org/news/2020/08/nih-imposes-outrageous-conditions-resuming-coronavirus-
grant-targeted-trump
Gain of Function Research: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996883/
https://www.telegraph.co.uk/global-health/science-and-disease/exclusive-mission-really-big-step-
forward-understand-covid-19/
https://www.nature.com/news/engineered-bat-virus-stirs-debate-over-risky-research-%201.18787
https://www.scmp.com/news/china/science/article/3111314/who-names-line-international-team-
looking-coronavirus-origins
https://www.nature.com/articles/d41586-020-02473-4
https://www.pressreader.com/uk/the-mail-on-sunday/20210110/281831466368322
Articles of interest
* Origin and evolution of pathogenic coronaviruses Nature Reviews Microbiology volume 17,
pages181-192(2019) Authors - Jie Cui, Fang Li & Zheng-Li Shi This work was jointly funded by the
Strategic Priority Research Program of the Chinese Academy of Sciences (XDB29010000), the
National Natural Science Foundation of China (31621061) and the US National Institutes of Health
(NIH) National Institute of Allergy and Infection Diseases (R01AI110964) to Z.-L.S; NIH grants
(R01AI089728 and R01AI110700) to F.L.; the CAS Pioneer Hundred Talents Program to J.C.; and the
Wuhan Institute of Virology (WIV) "One-Three-Five" Strategic Program (WIV-135-TP1) to J.C. and
Z.-L.S
*
Discovery of Novel Bat Coronaviruses in South China That Use the Same Receptor as Middle
East Respiratory Syndrome Coronavirus Journal of Virology Jun 2018, 92 (13) e00116-18 Authors -
Chu-Ming Luo, Ning Wang, Xing-Lou Yang, Hai-Zhou Liu, Wei Zhang, Bei Li, Ben Hu, Cheng Peng, Qi-
Bin Geng, Guang-Jian Zhu, Fang Li, Zheng-Li Shi This study was jointly funded by the Scientific
and Technological Basis Special Project (2013FY113500) from the Ministry of Science and
Technology of the People's Republic of China to Z.-L.S., a USAID Emerging Pandemic Threats
PREDICT project grant (Cooperative Agreement no. AID-OAA-A-14-00102), NIH grants (R01AI110964 to
Z.-L.S.; R01AI089728 and R01AI110700 to F.L.), and the National Natural Science Foundation of
China (31727901) to Z.-L.S.UNCLASSIFIED//LES
UNCLASSIFIED//LES
Released by Chairman Rand Paul
Released by Chairman Rand Paul
UNCLASSIFIED//LES
UNCLASSIFIED//LES
Released by Chairman Rand Paul

Summary:
Watcher-discovered document from hsgac-newsroom (2026.07.17_Daszak-CBP-Package_-1-1.pdf), auto-indexed 2026-07-27.

Excerpt: Released by Chairman Rand Paul Released by Chairman Rand Paul Released by Chairman Rand Paul Released by Chairman Rand Paul Released by Chairman Rand Paul Photos #Preview 1. 2. Date of Birth 1.DASZAK, PETERPlace of Birth 1.Place of Birth:DUKINFIELD UNITED KINGDOM GB/GBR City:DUKINFIELD Country:United Kingdom (GB/GBR) 2.Country:United Kingdom (GB/GBR) Citizenship United States (US/USA) Disposition 1.Disposition Category: Disposition: ActionUNCLASSIFIED//LES UNCLASSIFIED//LES  Released by Chairman Rand Paul Disposition Reason 1.Remarks:Referred to .  FBI requested not to stop subject.  No further  NTC action Records #Person Record Name S ubtype Record ID Code 1. 2.PNR 3.PNR 4.TECS Conveyances 1.MOT:Air-Commercial Est Departure:01/12/2021 01:00:00 EST Est Arrival:01/12/2021 13:15:00 EST…